Form 4 for ENVB Enveric Biosciences, Inc.
Accepted 2024-10-11 00:00:00 ET · period of report 2024-10-09 · accession 0001415889-24-025055 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-11 | 2024-10-09 | ENVB | PASQUALONE FRANK | Dir | A - Grant | $0.00 | +47.7K | 48.7K | +4,773% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-09 | A | A | 47,733 | $0.00 | 48,733 | D | — | — | (F1) Represents restricted stock granted to the reporting person pursuant to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan, as amended (the "Plan"). Such shares shall vest in full on December 31, 2024, subject to the terms and conditions of the Plan and the reporting person's restricted stock award agreement. |